Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season

The European Medicines Agency requires Enhanced Passive Safety Surveillance (EPSS) for all seasonal influenza vaccines. Here, we report the EPSS results for the trivalent inactivated influenza vaccine (IIV3; Vaxigrip®) and the quadrivalent inactivated influenza vaccine (IIV4; VaxigripTetraTM) during...

Descripció completa

Dades bibliogràfiques

Autors principals:	Laurence Serradell, Sophie Wagué, Annick Moureau, Markku Nissilä, Anne-Laure Chabanon
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2021-04-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	influenza vaccines vaccination safety safety surveillance seasonal influenza adverse reaction adverse event reactogenicity immunization
Accés en línia:	http://dx.doi.org/10.1080/21645515.2020.1804247
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!